These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23882708)

  • 1. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
    Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.
    Aroda VR; Conway BN; Fernandez SJ; Matter NI; Maynard JD; Orchard TJ; Ratner RE
    Diabetes Technol Ther; 2013 Feb; 15(2):117-23. PubMed ID: 23305087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
    Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.
    Tomaszewski EL; Orchard TJ; Hawkins MS; Conway RBN; Buchanich JM; Maynard J; Songer T; Costacou T
    J Diabetes Sci Technol; 2021 Nov; 15(6):1368-1376. PubMed ID: 33993770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.
    Conway B; Edmundowicz D; Matter N; Maynard J; Orchard T
    Diabetes Technol Ther; 2010 May; 12(5):339-45. PubMed ID: 20388043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
    Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
    Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
    Braffett BH; Lorenzi GM; Cowie CC; Gao X; Bainbridge KE; Cruickshanks KJ; Kramer JR; Gubitosi-Klug RA; Larkin ME; Barnie A; Lachin JM; Schade DS;
    Endocr Pract; 2019 Dec; 25(12):1243-1254. PubMed ID: 31412233
    [No Abstract]   [Full Text] [Related]  

  • 10. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.
    Orchard TJ; Lyons TJ; Cleary PA; Braffett BH; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
    Diabetes Care; 2013 Oct; 36(10):3146-53. PubMed ID: 23813757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes.
    Conway BN; Aroda VR; Maynard JD; Matter N; Fernandez S; Ratner RE; Orchard TJ
    Diabetes Care; 2012 Nov; 35(11):2331-6. PubMed ID: 22851597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.
    Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF
    Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
    Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
    Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.
    Felipe DL; Hempe JM; Liu S; Matter N; Maynard J; Linares C; Chalew SA
    Diabetes Care; 2011 Aug; 34(8):1816-20. PubMed ID: 21636794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BEK; Horak KL; Maynard JD; Lee KE; Klein R
    Ophthalmic Epidemiol; 2017 Aug; 24(4):211-216. PubMed ID: 28287861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
    Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
    Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.